BRIEF published on 10/21/2024 at 14:06, 1 year 3 months ago Mainz BioMed Releases Mid-Year 2024 Financial Results Financial Results FDA Feedback Mainz Biomed ColoAlert® Cancer Detection
BRIEF published on 10/21/2024 at 14:06, 1 year 3 months ago Mainz BioMed publie ses résultats financiers du premier semestre 2024 Résultats Financiers ColoAlert® Mayence Biomed Détection Du Cancer Commentaires De La FDA
PRESS RELEASE published on 10/21/2024 at 14:01, 1 year 3 months ago Mainz Biomed Reports Mid-Year 2024 Financial Results and Provides Corporate Update Mainz Biomed reports 4% revenue increase in Mid-Year 2024 Financial Results with 32% decrease in loss from operations. Company highlights successful studies at ASCO and outlines strategic plan for 2025 Financial Results Corporate Update ColoAlert Mainz Biomed EAArly DETECT
BRIEF published on 10/08/2024 at 14:05, 1 year 4 months ago Mainz Biomed Sees Surge in Demand for Enhanced ColoAlert Screening Mainz Biomed Colorectal Cancer Screening Test Enhanced ColoAlert GANZIMMUN Diagnostics
BRIEF published on 10/08/2024 at 14:05, 1 year 4 months ago Mainz Biomed constate une augmentation de la demande pour le dépistage amélioré ColoAlert Cancer Colorectal Mayence Biomed Test De Dépistage ColoAlert Amélioré Diagnostic GANZIMMUN
PRESS RELEASE published on 10/08/2024 at 14:00, 1 year 4 months ago Mainz Biomed Reports Increased Demand for Enhanced ColoAlert, Existing Partners to Transition to New Version Mainz Biomed reports increasing demand for enhanced ColoAlert product leading to transition by existing partners to new version, featuring at Medizinische Woche Baden-Baden ColoAlert Mainz Biomed Partners Demand Medizinische Woche
BRIEF published on 10/01/2024 at 14:06, 1 year 4 months ago Mainz Biomed's CEO Projects Substantial Growth and U.S. FDA Trials in 2025 Cancer Diagnostics Mainz Biomed CRC Screening FDA Trials Growth 2025
BRIEF published on 10/01/2024 at 14:06, 1 year 4 months ago Le PDG de Mainz Biomed prévoit une croissance substantielle et des essais cliniques auprès de la FDA américaine en 2025 Mayence Biomed Dépistage Du Cancer Colorectal Diagnostic Du Cancer Essais De La FDA Croissance 2025
PRESS RELEASE published on 10/01/2024 at 14:01, 1 year 4 months ago Mainz Biomed Publishes CEO Statement; CEO Guido Baechler Eyes Major Growth and U.S. FDA Trials in 2025 Mainz Biomed CEO Guido Baechler shares plans for major growth and U.S. FDA trials in 2025, highlighting innovative cancer diagnostics and upcoming clinical developments Growth Cancer Diagnostics CEO Statement Mainz Biomed FDA Trials
BRIEF published on 09/18/2024 at 14:06, 1 year 4 months ago Mainz Biomed Announces Petra Smeltzer Starke as Brand Ambassador Cancer Screening Early Detection Brand Ambassador Biomed FDA Trial
Published on 02/10/2026 at 14:00, 34 minutes ago Horizon Aircraft Partners with North Aircraft Industries to Manufacture the Wings for the Cavorite X7
Published on 02/10/2026 at 14:00, 34 minutes ago BTU Metals Initiates Geophysical Program at Its Dixie East Property in Red Lake in Preparation for Drilling Drilling Planned for Three Ontario Gold Projects in 2026
Published on 02/10/2026 at 14:00, 34 minutes ago Kestrel Gold Reports 2025 Diamond Drill Results from its 100% owned QCM Gold Property, British Columbia (Pursuant to Option to earn in Agreement with Centerra Gold) with Grades reporting up to 72 metres of 0.60 g/t Gold on the Main Zone and 22.35 metres o
Published on 02/10/2026 at 14:00, 34 minutes ago Datavault AI Recaps High-Impact Super Bowl LX Weekend with NFL Alumni, Live ADIO(R) Activations, DVHOLO(TM) and Tokenization
Published on 02/10/2026 at 13:30, 1 hour 4 minutes ago Revival Gold Intercepts 1.0 g/t Gold Over 30 Meters and Extends Mineralization at Mercur Project in Utah
Published on 02/10/2026 at 14:05, 29 minutes ago KPS CAPITAL PARTNERS TO ACQUIRE THE WELLS COMPANIES, INC.
Published on 02/10/2026 at 14:00, 34 minutes ago CorTec Announces Successful Second Human Implantation of Its Brain-Computer Interface (BCI) System
Published on 02/10/2026 at 13:39, 55 minutes ago EQS-Adhoc: Salzgitter Aktiengesellschaft: Preliminary financials for the financial year 2025; Management Guidance 2026 approved
Published on 02/10/2026 at 13:39, 55 minutes ago Bernd Spalt fulfils current contract – but does not seek extension
Published on 02/10/2026 at 13:35, 59 minutes ago Bernd Spalt fulfils current contract – but does not seek extension
Published on 02/09/2026 at 18:00, 20 hours 34 minutes ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 janvier 2026
Published on 02/09/2026 at 17:45, 20 hours 49 minutes ago Declaration of voting rights at the end of January 2026
Published on 02/09/2026 at 17:45, 20 hours 49 minutes ago DAMARTEX / Droits de vote bruts et réels au 31 janvier 2026
Published on 02/09/2026 at 17:45, 20 hours 49 minutes ago Déclaration des droits de vote à fin janvier 2026
Published on 02/09/2026 at 17:45, 20 hours 49 minutes ago Déclaration des droits de vote à fin janvier 2026
